MENU
+Compare
BEAT
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$1.03
Change
-$0.08 (-7.21%)
Capitalization
34.82M

BEAT Heartbeam Forecast, Technical & Fundamental Analysis

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting... Show more

BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BEAT with price predictions
Aug 15, 2025

BEAT's Indicator enters downward trend

The Aroon Indicator for BEAT entered a downward trend on August 15, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 182 similar instances where the Aroon Indicator formed such a pattern. In of the 182 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BEAT's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where BEAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on BEAT as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BEAT just turned positive on August 12, 2025. Looking at past instances where BEAT's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

BEAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.326) is normal, around the industry mean (10.946). P/E Ratio (0.000) is within average values for comparable stocks, (80.862). BEAT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.386). Dividend Yield (0.000) settles around the average of (0.063) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (86.429).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BEAT is expected to report earnings to rise 26.67% to -18 cents per share on November 06

Heartbeam BEAT Stock Earnings Reports
Q3'25
Est.
$-0.19
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.04
The last earnings report on August 13 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 79.32K shares outstanding, the current market capitalization sits at 34.82M.
A.I. Advisor
published General Information

General Information

a wireless medical technology company, which focuses on the delivery of health information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2118 Walsh Avenue
Phone
+1 408 899-4443
Employees
15
Web
https://www.heartbeam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTEV71.613.80
+5.60%
Claritev Corporation
SCOR6.650.20
+3.11%
comScore
OR30.55-0.08
-0.26%
OR Royalties Inc.
BTI57.15-0.27
-0.47%
British American Tobacco plc
LXEO4.72-0.07
-1.46%
Lexeo Therapeutics

BEAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAT has been loosely correlated with SNOW. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BEAT jumps, then SNOW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAT
1D Price
Change %
BEAT100%
-7.21%
SNOW - BEAT
37%
Loosely correlated
+2.14%
APPN - BEAT
33%
Poorly correlated
-0.34%
MNDY - BEAT
32%
Poorly correlated
-0.67%
ZS - BEAT
31%
Poorly correlated
+1.47%
CRM - BEAT
31%
Poorly correlated
+3.89%
More

Groups containing BEAT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAT
1D Price
Change %
BEAT100%
-7.21%
Health Services
category (440 stocks)
15%
Poorly correlated
-0.02%
Services to the Health Industry
category (96 stocks)
-1%
Poorly correlated
+0.91%